Acute Lymphoblastic Leukemia (ALL)
Showing 1 - 25 of 38
Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States
Recruiting
- Acute Myelogenous Leukemia (AML)
- +5 more
- Conditioning Chemotherapy
- Cord blood graft
-
Basking Ridge, New Jersey
- +6 more
May 22, 2023
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,
Recruiting
- Acute Myeloid Leukemia (AML)
- +3 more
- Idasanutlin
- +6 more
-
Phoenix, Arizona
- +19 more
Jan 18, 2023
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Guediawaye GOL SUD (Pyronaridine Tetraphosphate)
Recruiting
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Pyronaridine Tetraphosphate
-
Guediawaye GOL SUD, Dakar, SenegalDalal Jamm Hospital
Nov 23, 2022
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Carfilzomib, Dexamethasone, Mitoxantrone)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- Carfilzomib
- +10 more
-
Orange, California
- +86 more
Nov 14, 2022
Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)
No longer available
- Acute Lymphoblastic Leukemia (ALL)
- (no location specified)
Aug 5, 2022
Acute Lymphoblastic Leukemia (ALL) Trial in New Brunswick, Toronto (Bright Ideas - CIN Training)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- Bright Ideas - CIN Training
-
New Brunswick, New Jersey
- +1 more
Jul 30, 2022
CAR T Cells Real World Evidence Study Based on French Hospital
Completed
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Acute Lymphoblastic Leukemia (ALL)
- KYMRIAH
- YESCARTA
-
East Hanover, New JerseyNovartis Investigative Site
Jun 29, 2022
Bio-CAR-T BS Study
Recruiting
- Diffuse Large B Cell Lymphoma (DLBCL)
- +2 more
-
Brescia, ItalyASST Spedali Civili di Brescia
May 5, 2022
Acute Lymphoblastic Leukemia (ALL), Non Hodgkin Lymphoma (NHL) Trial in Zhengzhou, Hangzhou (CD19-UCART)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- Non Hodgkin Lymphoma (NHL)
- CD19-UCART
-
Zhengzhou, Henan, China
- +1 more
Apr 2, 2022
Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)
Available
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
- (no location specified)
Mar 28, 2022
Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Trial in Australia, United States (Navitoclax, Chemotherapy,
Completed
- Acute Lymphoblastic Leukemia (ALL)
- Lymphoblastic Lymphoma
- Navitoclax
- +2 more
-
Duarte, California
- +14 more
Oct 7, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Acute Lymphoblastic Leukemia (ALL) Trial in United States (Vincristine Sulfate Liposomes Injection (VSLI), Vincristine Sulfate
Terminated
- Acute Lymphoblastic Leukemia (ALL)
- Vincristine Sulfate Liposomes Injection (VSLI)
- Vincristine Sulfate Injection (VSI)
-
La Jolla, California
- +14 more
Sep 6, 2021
Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory
Recruiting
- Myeloid Leukemia, Chronic
- +8 more
- Conventional T cells (Tcon) and Regulatory T cells (Treg)
-
Palo Alto, CaliforniaStanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Maywood, Durham
Completed
- Acute Lymphoblastic Leukemia (ALL)
- +4 more
-
Maywood, Illinois
- +1 more
Aug 1, 2021
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))
Completed
- Acute Lymphoblastic Leukemia (ALL)
- Marqibo® (vincristine sulfate liposomes injection)
-
Los Angeles, California
- +32 more
Feb 8, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
-
Los Angeles, California
- +51 more
Jan 7, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)
Completed
- Hematological Malignancies
- +3 more
-
Los Angeles, California
- +14 more
Oct 1, 2020
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Bortezomib)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
-
Clayton, Victoria, Australia
- +14 more
Aug 14, 2020
Acute Lymphoblastic Leukemia (ALL) Trial in Rennes (Impact of CD9 expression level on motility assays, Post-transcriptional
Completed
- Acute Lymphoblastic Leukemia (ALL)
- Impact of CD9 expression level on motility assays
- Post-transcriptional regulation of CD9
-
Rennes, FranceRennes University Hospital
Aug 11, 2020
Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS
Recruiting
- Chronic Myeloid Leukemia (CML)
- +5 more
- CliniMACS CD34+ Reagent System
- +8 more
-
New York, New YorkColumbia University Medical Center
Jun 17, 2020
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States
Completed
- Acute Myeloid Leukemia (AML)
- +3 more
- Selinexor
- +3 more
-
Phoenix, Arizona
- +5 more
Mar 25, 2020
Genetic Study of Familial Acute Lymphoblastic Leukemia
Completed
- Acute Lymphoblastic Leukemia (ALL)
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 9, 2019
Non-interventional, Long-term Follow-up of Subjects Who
Unknown status
- Acute Myelogenous Leukemia (AML)
- +3 more
- non intervational
-
Haifa, IsraelRambam Medical Center
Nov 24, 2019